Advertisement

Current Surgery Reports

, 3:38 | Cite as

Surgical Management of Uveitis Patients

  • Lisa J. FaiaEmail author
Ophthalmologic Surgery (K. Drenser, Section Editor)
  • 43 Downloads
Part of the following topical collections:
  1. Ophthalmologic Surgery

Abstract

Uveitis is a sight threatening disease which requires special considerations for treatments and surgical management. Proper pre-operative evaluation and treatment of these patients can drastically affect their surgical outcomes. Eyes should be quiescent whenever possible before surgical intervention and post-operative care maximized to prevent re-activation of inflammation. Surgical intervention can be used in aiding of the diagnosis as well as treating the disease and its complications. Patient should be made aware of the complexities of their disease and the necessary steps to give them the best results possible.

Keywords

Uveitis Surgery Vitrectomy Cataract Retinal detachment Hypotony 

Notes

Supplementary material

Supplementary material 1 (MP4 68613 kb)

Supplementary material 2 (MP4 104598 kb)

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Suttorp-Schulten MSA, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844–8.PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Eckardt C, Bacskulin A. Vitrectomy in intermediate uveitis. Dev Ophthalmol. 1992;23:232–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Heiligenhaus A, Bornfeld N, Foerster MH, Weissing A. Long-term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol. 1994;78:549–54.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Scott RA, Sullivan PM, Aylward GW, Pavesio CE, et al. The effect of pars planitis complicated by vitreous hemorrhage: visual outcome and long-term follow-up. Am J Ophthalmol. 2001;131:514–5.CrossRefGoogle Scholar
  5. 5.
    Sikic J, Suic JP. Surgical treatment of uveitis. Caoll Antropol. 2001;25(Suppl):71–6.Google Scholar
  6. 6.
    Soylu M, Demircan N, Pelit A. Pars plana vitrectomy in ocular Behçet’s disease. Int Ophthalmol. 2001;24:219–23.CrossRefPubMedGoogle Scholar
  7. 7.
    Stavrou P, Baltatzis S, Letko E, Samson CM, Chris-ten W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflamm. 2001;9:141–51.CrossRefPubMedGoogle Scholar
  8. 8.
    Ieki Y, Kiryu J, Kita M, et al. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment. Ocul Immunol Inflamm. 2004;12:35–43.CrossRefPubMedGoogle Scholar
  9. 9.
    Nolle B, Eckardt C. Vitrectomy in multifocal chorioretinitis. Ger J Ophthalmol. 1993;2:14–9.PubMedGoogle Scholar
  10. 10.
    Bovey EH, Herbort CP. Vitrectomy in the management of uveitis. Ocul Immunol Inflamm. 2000;8:285–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Dugel PU, Rao NA, Ozler S, Liggett PE, et al. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study. Ophthalmology. 1992;99:1535–41.CrossRefPubMedGoogle Scholar
  12. 12.
    Kiryu J, Kita M, Tanabe T, Yamashiro K, et al. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology. 2001;108:1140–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Wiechens B, Nolle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239:474–81.CrossRefPubMedGoogle Scholar
  14. 14.
    Dev S, Mieler WF, Pulido JS, Mittra RA. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Ophthalmology. 1999;106:1086–90.CrossRefPubMedGoogle Scholar
  15. 15.
    Kiryu J, Kita M, Tanabe T, Yamashiro K, et al. Pars plana vitrectomy for epiretinal membrane associated with sarcoidosis. Jpn J Ophthalmol. 2003;47:479–83.CrossRefPubMedGoogle Scholar
  16. 16.
    Verbraeken H. Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results. Graefes Arch Clin Exp Ophthalmol. 1996;234:288–93.CrossRefPubMedGoogle Scholar
  17. 17.
    Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995;113(12):1479–96.CrossRefGoogle Scholar
  18. 18.
    Hagler WS, Jarrett WH II, Chang M. Rhegmatogenous retinal detachment following chorioretinal inflammatory disease. Am J Ophthalmol. 1978;86:373–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Kaplan HJ. Surgical treatment of intermediate uveitis. Dev Ophthalmol. 1992;23:185–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Foster CS. Vitrectomy in the management of uveitis. Ophthalmology. 1988;95:1011–2.CrossRefPubMedGoogle Scholar
  21. 21.
    Diamond JG, Kaplan HJ. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol. 1978;19:1798–804.CrossRefGoogle Scholar
  22. 22.
    Flynn HW Jr, Davis JL, Culbertson WW. Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis. Ophthalmology. 1988;95:1114–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Androudi S, Ahmed M, Fiore T, et al. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg. 2005;31:472–8.CrossRefPubMedGoogle Scholar
  24. 24.
    •• Mudhar HS, Sheard R. Diagnostic cellular yield is superior with full pars plana vitrectomy compared with core vitreous biopsy. Eye. 2013;27(1):50–5. Study demonstrating the benefits of a complete vitrectomy on the diagnostic yield for primary vitreoretinal lymphoma. Google Scholar
  25. 25.
    Becker M, Davis JL. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140:1096–105.CrossRefPubMedGoogle Scholar
  26. 26.
    • Yeh S, Weichel ED, Faia LJ, Albini TA, Wroblewski KK, Stetler-Stevenson M, Ruiz P, Sen HN, Chan CC, Nussenblatt RB. 25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma. Br J Ophthalmol. 2010;94(5):633–8. Study demonstrating that yield is not dependent on gauge choice. Google Scholar
  27. 27.
    Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE. Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology. 2004;111(9):1762–7.PubMedGoogle Scholar
  28. 28.
    Alio JL, International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery, et al. Comparative performance of intraocular lens in eye with cataract and uveitis. J Cataract Refract Surg. 2002;28(12):2096–108.CrossRefPubMedGoogle Scholar
  29. 29.
    Kerkhoff FT, Lamberts QJ, van den Biesen PR, et al. Rhegmatogenous retinal detachment and uveitis. Ophthalmology. 2003;110:427–31.CrossRefPubMedGoogle Scholar
  30. 30.
    Hillenkamp J, Nölle B, Bruns C, Rautenberg P, Fickenscher H, Roider J. Acute retinal necrosis: clinical features, early vitrectomy, and outcomes. Ophthalmology. 2009;116(10):1971–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Holland G. The progressive outer retinal necrosis syndrome. Int Ophthalmol. 1994;18:163–5.CrossRefPubMedGoogle Scholar
  32. 32.
    • Jabs DA, Ahuja A, Van Natta M, et al. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology 2010;117:2152–61. Study demonstrating the long term complications seen with CMV. Google Scholar
  33. 33.
    Bosch-Driessen LH, Karimi S, Stilma JS, et al. Retinal detachment in ocular toxoplasmosis. Ophthalmology. 2000;107:36–40.CrossRefPubMedGoogle Scholar
  34. 34.
    Friedman C, Knox D. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthal. 1969;81:481–93.CrossRefGoogle Scholar
  35. 35.
    Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1996;122:309–24.CrossRefPubMedGoogle Scholar
  36. 36.
    Adan A, Giralt J, Alvarez G, et al. Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis. Eur J Ophthalmol. 2009;19:1039–43.PubMedGoogle Scholar
  37. 37.
    Stewart J, Cubillan L, Cunningham E Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005;25:1005–13.CrossRefPubMedGoogle Scholar
  38. 38.
    Brockhurst RJ. Retinoschisis. Complication of peripheral uveitis. Arc Ophthalmol. 1981;99:1998–9.CrossRefGoogle Scholar
  39. 39.
    Hirokawa H, Takahashi M, Trempe CL. Vitreous changes in peripheral uveitis. Arch Ophthalmol. 1985;103:1704–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Morse LS, McCuen BW. The use of silicone oil in uveitis and hypotony. Retina. 1991;11:399–404.CrossRefPubMedGoogle Scholar
  41. 41.
    de Smet MD, Gunning F, Feenstra R. The surgical management of chronic hypotony due to uveitis. Eye. 2005;19:60–4.CrossRefPubMedGoogle Scholar
  42. 42.
    •• Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group. Quality of life and risks associated with systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: fifty-four-month results of the multicenter uveitis steroid treatment trial and follow-up study. Ophthalmology. 2015;122(10):1976–86. Long term study revealing the risks associated with both systemic immunosuppression and the fluocinolone acetonide implant. Google Scholar
  43. 43.
    • de Smet MD, Julian K. Volume 3: Section 3: Complicated forms of retinal detachment; Chapter 112, Management of combined inflammatory and RRD. In: Ryan SJ, Wilkinson CP, Wiedemann P, editors. Retina, 5th ed. (pp. 1902–1911). New York: Elsevier; 2013. Textbook chapter discussing the management of complex, inflammatory retinal detachments. Google Scholar
  44. 44.
    Blumenkranz M, Clarkson J, Culbertson W, Flynn HW, et al. Vitrectomy for retinal detachment associated with acute retinal necrosis. Am J Ophthalmol. 1988;106:426–9.CrossRefPubMedGoogle Scholar
  45. 45.
    Kreiger AE, Gonzales CR. Management of combined inflammatory and rhegmatogenous retinal detachments (AIDS and ARN). In: Ryan SJ, editor. Retina, vol. 3. St. Louis: Moseby; 2005.Google Scholar
  46. 46.
    Amin HI, McDonald HR, Han DP, Jaffe GJ. Vitrectomy update for macular traction in ocular toxocariasis. Retina. 2000;20:80–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media New York 2015

Authors and Affiliations

  1. 1.Royal OakUSA

Personalised recommendations